Showing 15,421 - 15,440 results of 20,793 for search '"therapy"', query time: 0.14s Refine Results
  1. 15421

    Achievement of Therapeutic Goals with Low-Dose Imiglucerase in Gaucher Disease: A Single-Center Experience by Irina Tukan, Irith Hadas-Halpern, Gheona Altarescu, Ayala Abrahamov, Deborah Elstein, Ari Zimran

    Published 2013-01-01
    “…Disease-specific enzyme replacement therapy (ERT) has been shown to reverse or ameliorate disease-specific hepatosplenomegaly and anemia and thrombocytopenia. …”
    Get full text
    Article
  2. 15422

    Negative Pressure Smart Patch to Sense and Heal the Wound by Xing Liu, Peng Zhao, Xiaozhuo Wu, Yawei Zhao, Feifan Zhou, Ying Luo, Xiaoli Jia, Wen Zhong, Malcolm Xing, Guozhong Lyu

    Published 2025-01-01
    “…Abstract Negative pressure wound therapy (NPWT) offers significant advantages in terms of rate and time for healing through generating sub‐vacuum to draw out inflammatory exudate and promote wound closure. …”
    Get full text
    Article
  3. 15423
  4. 15424

    Exertional Myopathy in a Juvenile Green Sea Turtle (Chelonia mydas) Entangled in a Large Mesh Gillnet by Brianne E. Phillips, Sarah A. Cannizzo, Matthew H. Godfrey, Brian A. Stacy, Craig A. Harms

    Published 2015-01-01
    “…Treatment with appropriate fluid therapy and supportive care may mitigate the effects of exertional myopathy in some cases.…”
    Get full text
    Article
  5. 15425

    Clinical utility of tumour mutational burden on efficacy of immune checkpoint inhibitors in malignant solid tumours: protocol for a systematic review and meta-analysis by Xiaoguang Yang, Yunming Li, Xuemei Xiang, Wang Guo, Pengfei Zhou

    Published 2022-08-01
    “…We plan to conduct a subgroup analysis on age, sex, area, number of patients (high/low TMB), cancer type, tumour size, stage, line of therapy, TMB sequencing method, type of immunotherapy and follow-up period.Ethics and dissemination Ethical approval and informed consent are not needed, as the study will be a literature review and will not involve direct contact with patients or alterations to patient care. …”
    Get full text
    Article
  6. 15426

    Community-Based 4-Level Intervention Targeting Depression and Suicidal Behavior in Europe: Protocol for an Implementation Project by Katharina Schnitzspahn, Kahar Abdulla, Ella Arensman, Chantal Van Audenhove, Rainer Mere, Victor Pérez Sola, Merike Sisask, András Székely, Piotr Toczyski, Ulrich Hegerl

    Published 2025-01-01
    “…Activities comprise the digital iFightDepression tool, a guided self-management tool based on cognitive behavioral therapy. ObjectiveThis study aimed to present the European Union–cofunded EAAD-Best study protocol, aiming at the implementation, dissemination, and evaluation of the 4-level intervention and the iFightDepression tool in several countries across Europe. …”
    Get full text
    Article
  7. 15427

    Synergistic Approach of High-Precision 3D Printing and Low Cell Adhesion for Enhanced Self-Assembled Spheroid Formation by Chunxiang Lu, Aoxiang Jin, Chuang Gao, Hao Qiao, Huazhen Liu, Yi Zhang, Wenbin Sun, Shih-Mo Yang, Yuanyuan Liu

    Published 2024-12-01
    “…This platform provides an efficient and cost-effective solution for biosensing applications, such as drug screening, disease modeling, and personalized therapy monitoring. Furthermore, the chip shows significant potential for real-time in vitro monitoring of cellular viability, reaction kinetics, and drug sensitivity, offering valuable advancements in biosensor technology for life sciences and medical applications.…”
    Get full text
    Article
  8. 15428

    The Effects of Anlotinib Combined with Chemotherapy following Progression on Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor-Positive Metastatic Breast Cancer by Ting Xu, Weili Xiong, Lili Zhang, Yuan Yuan

    Published 2024-01-01
    “…Purpose. Endocrine therapy combined with cyclin-dependent kinase (CDK) 4/6 inhibitors (CDK4/6i) is the preferred treatment for hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2–) metastatic breast cancer (MBC). …”
    Get full text
    Article
  9. 15429

    Insulinoma in Patients with Diabetes- A Systematic Review of Previously Reported Cases by Subhankar Chatterjee, Rana Bhattacharjee, Ritwik Ghosh, Partha P. Chakraborty, Anirban Sinha, Animesh Maiti

    Published 2024-12-01
    “…Surgical resection was done in 70.9% of cases, while 40% received drug therapy and 12.7% received both, with 20.7% overall mortality. …”
    Get full text
    Article
  10. 15430

    Downregulation of Gldc attenuates myocardial ischemia reperfusion injury in vitro by modulating Akt and NF-κB signalings by Lian Shuang, Youle Su, Yue Zhang

    Published 2025-01-01
    “…Abstract Myocardial ischemia/reperfusion injury (MIRI) is a serious clinical complication that is caused by reperfusion therapy following myocardial infarction (MI). Mitochondria-related genes (Mito-RGs) play important roles in multiple diseases. …”
    Get full text
    Article
  11. 15431

    Hepatocellular Carcinoma: Current Management and Future Development—Improved Outcomes with Surgical Resection by Yoji Kishi, Kiyoshi Hasegawa, Yasuhiko Sugawara, Norihiro Kokudo

    Published 2011-01-01
    “…Multimodality approaches combining other local ablation or systemic therapy may help improve the prognosis. On the other hand, minimally invasive, or laparoscopic, hepatectomy has become popular over the last decade. …”
    Get full text
    Article
  12. 15432
  13. 15433

    Orthostatic Dysregulation during Postural Change on the Dental Chair and Intraoperative Monitoring by Heart Rate Variability Analysis by Yukihiro Momota, Shigemasa Tomioka, Mayuko Furukita, Kenji Fujisawa, Hideyuki Takano, Masayuki Azuma

    Published 2014-01-01
    “…We measured autonomic activity in a patient with OD during dental therapy and assessed the clinical significance of HRV analysis for OD. …”
    Get full text
    Article
  14. 15434

    The Effects of Alpha Interferon on the Development of Autoimmune Thyroiditis in the NOD H2h4 Mouse by Yael Oppenheim, Grace Kim, Yoshiyuki Ban, Pamela Unger, Erlinda Concepcion, Takao Ando, Yaron Tomer

    Published 2003-01-01
    “…Alpha interferon (αIFN) therapy is known to induce thyroid autoimmunity in up to 40% of patients. …”
    Get full text
    Article
  15. 15435

    Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis by Gamal Shiha, Ahmed Nabil, Ahmed Lotfy, Reham Soliman, Ayman A. Hassan, Islam S. Ali, Doaa F. Gad, Faten Zahran

    Published 2020-01-01
    “…Nilotinib is a second-generation tyrosine kinase inhibitor, which showed antifibrotic efficacy. Stem cell therapy still has some limitations such as oncogenesis, unexpected differentiation, and ethical consideration. …”
    Get full text
    Article
  16. 15436

    Identifying the Predictors of Short Term Weight Loss Failure after Roux-En-Y Gastric Bypass by Effat Bahadori, Ali Jafarzadeh Esfehani, Leila Sadat Bahrami, Mohammad Reza Shadmand Foumani Moghadam, Ali Jangjoo, Mohsen Nematy, Afshin Roghani, Reza Rezvani

    Published 2022-01-01
    “…Gastric bypass surgery is a gold standard therapy for severe obesity. This study aimed to evaluate anthropometric predictors for short-term excess weight loss (EWL) after Roux-en-Y gastric bypass surgery (RYGB) in a sample of severely obese patients. …”
    Get full text
    Article
  17. 15437

    Clinical Scenarios for Discordant Anti-Xa by Jesus Vera-Aguilera, Hindi Yousef, Diego Beltran-Melgarejo, Teng Hugh Teng, Ramos Jan, Mary Mok, Carlos Vera-Aguilera, Eduardo Moreno-Aguilera

    Published 2016-01-01
    “…Anti-Xa test is widely used; however the assay underestimates heparin concentration in the presence of significant AT deficiency, pregnancy, end stage renal disease, and postthrombolysis and in patients with hyperbilirubinemia; limited published data evaluating the safety and effectiveness of anti-Xa assays for managing UH therapy is available. Conclusions and Relevance. To our knowledge this is the first paper that summarizes the most common causes in which this assay can be affected, several “day to day” clinical scenarios can modify the outcomes, and we concur that these rarely recognized scenarios can be affected by negative outcomes in the daily practice.…”
    Get full text
    Article
  18. 15438

    High Ano1 expression as key driver of resistance to radiation and cisplatin in HPV-negative head and neck squamous cell carcinoma by Solenne Bourdier, Anne-Sophie Fisch, Keziban Merve Alp, Ridhima Das, Philipp Mertins, Ingeborg Tinhofer

    Published 2025-01-01
    “…Copanlisib and afatinib were identified as promising candidates for combination therapy of 11q13-amplified HNSCC tumors. We demonstrated a predominant role for Ano1 in treatment resistance in Cyclin D1highAno1high HNSCC tumors and identified novel potential treatment combinations for this high-risk patient group.…”
    Get full text
    Article
  19. 15439

    Chronic Endometritis and Antimicrobial Resistance: Towards a Multidrug-Resistant Endometritis? An Expert Opinion by Francesco Di Gennaro, Giacomo Guido, Luisa Frallonardo, Laura Pennazzi, Miriana Bevilacqua, Pietro Locantore, Amerigo Vitagliano, Annalisa Saracino, Ettore Cicinelli

    Published 2025-01-01
    “…Treatment typically involves antibiotic therapy; however, the efficacy of these treatments is increasingly compromised by the rise of antimicrobial resistance (AMR). …”
    Get full text
    Article
  20. 15440

    Uninvestigated Dyspepsia and Heartburn Overlap Syndrome at Industrial Hub of Eastern Siberia by V. V. Tsukanov, A. V. Vasiutin, J. L. Tonkikh, E. V. Kasparov, O. V. Smirnova

    Published 2021-12-01
    “…Among total patients with the heartburn/uninvestigated dyspepsia overlap syndrome, only 33.3% systemically had proton pump inhibitors, and only 17.4% had a prokinetic therapy.Conclusion. The heartburn/uninvestigated dyspepsia overlap syndrome is an actual issue in the Krasnoyarsk population. …”
    Get full text
    Article